dailyai.report

Biologic medicines rely on engineered proteins rather than synthetic chemistry. MIT Tech Review highlights how AI reduces the high cost and failure rates inherent in traditional drug discovery. These tools predict protein folding and interaction with precision. This shift allows researchers to identify viable candidates faster, cutting years off the development timeline for new therapies.